0.612
price down icon1.77%   -0.011
pre-market  プレマーケット:  .61   -0.002   -0.33%
loading
前日終値:
$0.623
開ける:
$0.6101
24時間の取引高:
220.08K
Relative Volume:
0.23
時価総額:
$32.67M
収益:
-
当期純損益:
$-151.16M
株価収益率:
-0.2061
EPS:
-2.97
ネットキャッシュフロー:
$-130.08M
1週間 パフォーマンス:
-14.67%
1か月 パフォーマンス:
-44.36%
6か月 パフォーマンス:
-67.10%
1年 パフォーマンス:
-94.45%
1日の値動き範囲:
Value
$0.5955
$0.6272
1週間の範囲:
Value
$0.5912
$0.7398
52週間の値動き範囲:
Value
$0.5912
$17.82

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name
名前
Alx Oncology Holdings Inc
Name
セクター
Healthcare (1165)
Name
電話
650-466-7125
Name
住所
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
職員
80
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
ALXO's Discussions on Twitter

ALXO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ALXO
Alx Oncology Holdings Inc
0.612 32.67M 0 -151.16M -130.08M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-06 アップグレード Jefferies Hold → Buy
2024-12-19 ダウングレード Jefferies Buy → Hold
2024-03-08 ダウングレード Stifel Buy → Hold
2023-12-08 アップグレード Jefferies Hold → Buy
2021-12-22 ダウングレード Jefferies Buy → Hold
2021-09-30 開始されました Stifel Buy
2021-05-05 再開されました Credit Suisse Outperform
2021-04-26 再開されました Credit Suisse Outperform
2021-04-06 開始されました UBS Buy
2021-02-10 開始されました H.C. Wainwright Buy
2020-08-11 開始されました Cantor Fitzgerald Overweight
2020-08-11 開始されました Credit Suisse Outperform
2020-08-11 開始されました Jefferies Buy
2020-08-11 開始されました Piper Sandler Overweight
すべてを表示

Alx Oncology Holdings Inc (ALXO) 最新ニュース

pulisher
Mar 31, 2025

ALXO stock touches 52-week low at $0.65 amid market challenges - Investing.com

Mar 31, 2025
pulisher
Mar 21, 2025

Cantor Fitzgerald Raises Earnings Estimates for ALX Oncology - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

ALXO stock plunges to 52-week low of $0.73 amid market challenges - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

ALXO stock plunges to 52-week low of $0.73 amid market challenges By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Mar 20, 2025
pulisher
Mar 15, 2025

Why ALX Oncology Holdings Inc. (ALXO) Soared on Thursday - MSN

Mar 15, 2025
pulisher
Mar 13, 2025

ALXO stock touches 52-week low at $0.89 amid market challenges - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

ALXO stock touches 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 12, 2025

Insider Buying: Rekha Hemrajani Acquires 30,000 Shares of ALX On - GuruFocus.com

Mar 12, 2025
pulisher
Mar 10, 2025

ALX Oncology Holdings: Balancing Growth Potential and Uncertainty with a Hold Rating - TipRanks

Mar 10, 2025
pulisher
Mar 09, 2025

Stifel Nicolaus Lowers ALX Oncology (NASDAQ:ALXO) Price Target to $1.50 - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

ALX Oncology (NASDAQ:ALXO) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve

Mar 08, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge - PR Newswire

Mar 08, 2025
pulisher
Mar 08, 2025

Sun Valley buying at Canagold Resources (CCM) - The Globe and Mail

Mar 08, 2025
pulisher
Mar 08, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Jefferies Financial Group Upgrades ALX Oncology (NASDAQ:ALXO) to “Buy” - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Stifel cuts ALX Oncology stock target to $1.50, maintains hold By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Promising Developments in ALX Oncology’s Clinical Pipeline Justify Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Jefferies raises ALX Oncology stock to buy, target to $3 By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 06, 2025

ALX Oncology Reports 2024 Financial Results and Updates - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Micro-, Small-Cap Firms Dominate Market Rally - Insider Monkey

Mar 06, 2025
pulisher
Mar 06, 2025

Alx Oncology Holdings Inc Files For Mixed Shelf Of Up To $364.1 Million -March 06, 2025 at 05:35 pm EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology Holdings Inc (ALXO) Q4 2024 Earnings: EPS of -$0.55 Beats Estimate, Revenue Matches Forecast - GuruFocus.com

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology jumps as Jefferies upgrades on upside potential - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology stock jumps as Jefferies upgrades(ALXO:NASDAQ) - Seeking Alpha

Mar 06, 2025
pulisher
Mar 06, 2025

This Zscaler Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga India

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Barchart

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology Cuts 30% Workforce, Eliminates President And CSO Role Amid Pipeline Prioritization - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Jefferies Upgrades ALX Oncology to Buy From Hold, Adjusts Price Target to $3 From $2 - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Jefferies Upgrades ALX Oncology Holdings (ALXO) - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

ALX Oncology Holdings: Undervalued with Promising Catalysts and Growth Opportunities - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Jefferies raises ALX Oncology stock to buy, target to $3 - Investing.com

Mar 06, 2025
pulisher
Mar 05, 2025

ALX Oncology announces workforce reduction and officer departure By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

ALX Oncology announces workforce reduction and officer departure - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

ALX Oncology Announces Workforce Reduction and Leadership Change - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

ALX Oncology to Cut Workforce by 30% to Support New Clinical Initiatives -March 05, 2025 at 11:04 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

ALX Oncology Highlights Focused Evorpacept Development - GlobeNewswire

Mar 05, 2025
pulisher
Mar 05, 2025

ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

ALXO stock plunges to 52-week low, touches $0.96 By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

ALXO stock plunges to 52-week low, touches $0.96 - Investing.com

Mar 04, 2025
pulisher
Feb 28, 2025

ALX Oncology (ALXO) to Release Earnings on Thursday - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

When Will ALX Oncology Share Its 2024 Financial Performance? Key Date for Biotech Investors - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

ALX Oncology (ALXO) Projected to Post Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 25, 2025

H.C. Wainwright cuts ALX Oncology target to $5, keeps buy rating - MSN

Feb 25, 2025

Alx Oncology Holdings Inc (ALXO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Alx Oncology Holdings Inc (ALXO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Pons Jaume
PRESIDENT & CSO
Feb 19 '25
Sale
1.15
1,326
1,525
579,388
Lettmann Jason
CHIEF EXECUTIVE OFFICER
Feb 19 '25
Sale
1.15
2,159
2,483
170,270
Pinto Shelly
Interim CFO
Jan 06 '25
Sale
1.80
2,221
3,998
87,902
Pinto Shelly
Interim CFO
Dec 30 '24
Sale
1.58
1,426
2,253
90,123
Pons Jaume
PRESIDENT & CSO
Dec 30 '24
Sale
1.58
10,796
17,060
580,714
Hemrajani Rekha
Director
Dec 02 '24
Buy
1.55
30,000
46,404
33,000
Pinto Shelly
SVP, FINANCE AND CAO
Aug 14 '24
Sale
2.58
564
1,455
91,549
Randolph Sophia
CHIEF MEDICAL OFFICER
Aug 14 '24
Sale
2.58
1,365
3,522
325,711
Pons Jaume
PRESIDENT & CSO
Aug 14 '24
Sale
2.58
1,937
4,997
591,510
Pons Jaume
PRESIDENT & CSO
Jul 11 '24
Option Exercise
0.99
20,000
19,800
613,447
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):